Our findings suggest that NHANES III-derived RLD thresholds are not effective for identifying steatosis risk groups in unselected populations, where they appear to capture metabolically healthy individuals rather than those with pathological leptin insufficiency. The gene discussed is LEP; the disease is steatosis.